SCP's SePRO completes acquisition of Earth Science Laboratories
This acquisition advances SePRO's transformation into a water health platform.
See the latest news and media coverage for SCP. We track all announcements, press releases, and industry mentions in real time, all in one place.
European-focused mid-market private equity firm
stanley-capital.comLast updated
In short: SCP expanded SePRO’s water-health platform and LXO’s presence through acquisitions.
This acquisition advances SePRO's transformation into a water health platform.
The refinancing with Hayfin unlocks capital for M&A, and the Barhemsys acquisition expands LXO's US presence with a patented hospital product.
The acquisition adds satellite diagnostics for harmful algal blooms and aquatic weed management.
Key exit was Noden Pharma at 6.7x return. Invested in Qinecsa and Laboratoire X.O with $400m equity.
Stanley Capital Partners LLP (SCP) announced the acquisition of MyMeds&Me Limited (MMM) by its portfolio company Drug Safety and Pharmacovigilance Services Solutions (DSS). DSS is...
SePRO Corporation, a Carmel, Indiana-based specialty environmental restoration company focused on water quality, received an investment from Stanley Capital Partners and Goldman Sachs Alternatives...
Stanley Capital Partners (SCP) will leverage the generative AI boom to reach €200 million to €300 million of revenue with hyper-automation services company Roboyo, founding...
Roboyo is SCP's first resource efficiency investment MML initially invested in Roboyo in late 2020 SCP is a European mid-market private equity firm based in...
Track SCP and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to SCP and other trending companies.